,eighteen Sufferers taking these medicine may perhaps experience medication shortages, healthcare institutes could have to source safer options, and RAs could possibly be necessary to inspect the manufacturing premises to evaluate GMP compliance, suspend producing, or suggest corrective actions.21 RAs may possibly also have to evaluate the threats